JACOBS LEVY EQUITY MANAGEMENT, INC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 52 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$27,000
-49.1%
23,5570.0%0.00%
Q4 2021$53,000
-80.1%
23,557
-69.7%
0.00%
-100.0%
Q3 2021$266,000
+14.2%
77,7850.0%0.00%0.0%
Q2 2021$233,000
-76.5%
77,785
-74.7%
0.00%
-75.0%
Q1 2021$993,000
+228.8%
307,533
+116.0%
0.01%
+166.7%
Q4 2020$302,000
-7.1%
142,354
-48.7%
0.00%0.0%
Q3 2020$325,000
+29.5%
277,5500.0%0.00%0.0%
Q2 2020$251,000
+13.1%
277,550
+4.9%
0.00%0.0%
Q1 2020$222,000
+65.7%
264,549
+89.7%
0.00%
+200.0%
Q4 2019$134,000
-14.1%
139,453
-7.7%
0.00%
-50.0%
Q3 2019$156,000
-57.0%
151,136
-25.0%
0.00%
-60.0%
Q2 2019$363,000
+0.6%
201,438
+5.0%
0.01%0.0%
Q1 2019$361,000
+137.5%
191,927
+48.6%
0.01%
+66.7%
Q4 2018$152,000
-49.2%
129,127
+17.0%
0.00%
-25.0%
Q3 2018$299,000
-7.1%
110,354
-34.6%
0.00%
-20.0%
Q2 2018$322,000
-28.3%
168,727
-21.1%
0.01%
-28.6%
Q1 2018$449,000
+1.4%
213,827
-2.1%
0.01%
-12.5%
Q4 2017$443,000
+235.6%
218,427
+119.5%
0.01%
+166.7%
Q3 2017$132,000
-76.3%
99,527
-71.9%
0.00%
-75.0%
Q2 2017$556,000
-56.0%
353,891
-9.6%
0.01%
-53.8%
Q1 2017$1,265,000
+271.0%
391,671
+55.0%
0.03%
+271.4%
Q4 2016$341,000
+2031.2%
252,771
+2033.1%
0.01%
Q2 2016$16,000
-74.2%
11,8500.0%0.00%
-100.0%
Q1 2016$62,000
-33.3%
11,8500.0%0.00%
-50.0%
Q4 2015$93,000
-49.7%
11,850
-46.0%
0.00%
-50.0%
Q3 2015$185,000
-69.9%
21,950
-60.8%
0.00%
-66.7%
Q2 2015$614,000
-39.4%
56,050
-22.7%
0.01%
-29.4%
Q1 2015$1,013,000
-55.6%
72,485
-46.4%
0.02%
-56.4%
Q4 2014$2,282,000
+201.9%
135,108
+139.8%
0.04%
+200.0%
Q3 2014$756,00056,3500.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders